What does the Thyrocare Technologies Limited (THYROCARE) stock page cover?

Thyrocare Technologies Limited on Anvest includes delayed price context, valuation ratios, a one-year price range, and section-level research data when available.

What are the current headline metrics for THYROCARE?

Thyrocare Technologies Limited is currently shown with a delayed price near ₹456.3, P/E 50.74.

Does the THYROCARE page provide investment advice?

No. The THYROCARE page is built for research, comparison, and planning. It does not publish buy, sell, or hold recommendations.

Stocks›Healthcare

Watch Alert

Thyrocare Technologies Limited

THYROCARE · NSE · Healthcare · As of 30 Oct 2026Delayed / Sandbox EOD Data

₹456.30

−₹59.20 (−11.48%)(1D)

₹342.5552 Week Range₹662.00

Anvest Score

70/100

Valuation

5/100

Quality

100/100

Growth

90/100

Health

98/100

Momentum

55/100

Valuation
5
Quality
100
Growth
90
Health
98
Momentum
55

Loading company profile…

More Page Context

Research at a glance

Thyrocare Technologies Limited with delayed price, financials, ownership context, and peer links.

Latest price

₹456.3

Market cap

₹7,616 Cr

P/E ratio

50.74

P/B ratio

12.41

Dividend yield

Not available

ROE

Not available

RSI 14

36.55

1Y return

Not available

Thyrocare Technologies Limited FAQs

3 topics

Expand

Stocks›Healthcare

Watch Alert

Thyrocare Technologies Limited

THYROCARE · NSE · Healthcare · As of 30 Oct 2026Delayed / Sandbox EOD Data

₹456.30

−₹59.20 (−11.48%)(1D)

₹342.5552 Week Range₹662.00

Anvest Score

70/100

Valuation

5/100

Quality

100/100

Growth

90/100

Health

98/100

Momentum

55/100

Valuation
5
Quality
100
Growth
90
Health
98
Momentum
55

AI Company ProfileSign in to generate AI briefing

AI Snapshot

Thyrocare Technologies Limited is a prominent Indian diagnostic chain offering a wide range of tests, including preventive healthcare and specialized diagnostics. It operates across India, serving both individual customers and other healthcare providers.

Diagnostics & ResearchFounded:1996CEO/MD:Dr. Arokiaswamy VelumaniHQ:Navi Mumbai, Maharashtra

Business profile as of 2026-08-25

Business at a Glance

The Group's primary business segments are diagnostic testing services, which involve laboratory testing, and imaging services, including PET-CT scans and radiopharmaceutical sales.
Other activities include trading.

Revenue growth: +20.6%FY26 growth+16.3%3Y CAGR
EPS growth: +79.9%FY26 growth+36.3%3Y CAGR
CFO / PAT: 1.31×FY26

What Looks Strong

GrowthRevenue and net profit grew at +16% and +36% 3Y CAGR.
QualityQuality score is supported by healthy return on equity (ROE 27.8%).
Cash FlowOperating cash flow was 1.31× total net profit in FY26.

What to Watch

No material watchpoint identified from currently verified evidence.

Segment revenue, FY26 (consolidated, as filed): Diagnostic Testing Services 93%; Imaging Services 6%; Others <1%.
Share of segment profit before interest and tax, FY26: Diagnostic Testing Services 98%; Others 1%; Imaging Services <1%.
Thyrocare generates revenue by performing a vast array of diagnostic tests, including routine blood tests, specialized pathology, and preventive health check-ups.

FY26 (consolidated): revenue ₹829 cr, up 21% from ₹687 cr in FY25; net profit ₹163 cr, up 80% from ₹90.8 cr in FY25.
FY26 (consolidated): operating cash flow ₹213 cr (1.3× net profit); debt/equity 0.07×.
Latest quarter to Sep 2026 (consolidated): revenue ₹271 cr (up 25% year on year); net profit ₹15.2 cr.

The company's disclosures under SEBI (SAST) Regulations and Takeover Regulations indicate ongoing compliance activities

Loading company profile…

More Page Context

Research at a glance

Thyrocare Technologies Limited with delayed price, financials, ownership context, and peer links.

Latest price

₹456.3

Market cap

₹7,616 Cr

P/E ratio

50.74

P/B ratio

12.41

Dividend yield

Not available

ROE

Not available

RSI 14

36.55

1Y return

Not available

Thyrocare Technologies Limited FAQs

3 topics

Expand

AI Company ProfileSign in to generate AI briefing

AI Snapshot

Thyrocare Technologies Limited is a prominent Indian diagnostic chain offering a wide range of tests, including preventive healthcare and specialized diagnostics. It operates across India, serving both individual customers and other healthcare providers.

Diagnostics & ResearchFounded:1996CEO/MD:Dr. Arokiaswamy VelumaniHQ:Navi Mumbai, Maharashtra

Business profile as of 2026-08-25

Business at a Glance

The Group's primary business segments are diagnostic testing services, which involve laboratory testing, and imaging services, including PET-CT scans and radiopharmaceutical sales.
Other activities include trading.

Revenue growth: +20.6%FY26 growth+16.3%3Y CAGR
EPS growth: +79.9%FY26 growth+36.3%3Y CAGR
CFO / PAT: 1.31×FY26

What Looks Strong

GrowthRevenue and net profit grew at +16% and +36% 3Y CAGR.
QualityQuality score is supported by healthy return on equity (ROE 27.8%).
Cash FlowOperating cash flow was 1.31× total net profit in FY26.

What to Watch

No material watchpoint identified from currently verified evidence.

Segment revenue, FY26 (consolidated, as filed): Diagnostic Testing Services 93%; Imaging Services 6%; Others <1%.
Share of segment profit before interest and tax, FY26: Diagnostic Testing Services 98%; Others 1%; Imaging Services <1%.
Thyrocare generates revenue by performing a vast array of diagnostic tests, including routine blood tests, specialized pathology, and preventive health check-ups.

FY26 (consolidated): revenue ₹829 cr, up 21% from ₹687 cr in FY25; net profit ₹163 cr, up 80% from ₹90.8 cr in FY25.
FY26 (consolidated): operating cash flow ₹213 cr (1.3× net profit); debt/equity 0.07×.
Latest quarter to Sep 2026 (consolidated): revenue ₹271 cr (up 25% year on year); net profit ₹15.2 cr.

The company's disclosures under SEBI (SAST) Regulations and Takeover Regulations indicate ongoing compliance activities

Thyrocare Technologies Limited

Research at a glance

Thyrocare Technologies Limited FAQs

Thyrocare Technologies Limited

Business at a Glance

What Looks Strong

What to Watch

Research at a glance

Thyrocare Technologies Limited FAQs

Related paths

Related insights

METROPOLIS

VIJAYA

SYNGENE

The Complete Guide to Backtesting Stock Strategies in India (NSE & BSE)

Business at a Glance

What Looks Strong

What to Watch